Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas
2011
Rab25 as a Tumor Suppressor in Colon Cancer
publication
Evidence: moderate
Author Information
Author(s): Goldenring J R, Nam K T
Primary Institution: Nashville VA Medical Center and Vanderbilt University School of Medicine
Hypothesis
Is Rab25 a tumor suppressor in colon carcinogenesis?
Conclusion
Loss of Rab25 is associated with poorer prognosis in colon cancer and promotes tumorigenesis in mouse models.
Supporting Evidence
- Rab25 expression is decreased in human colon cancers independent of stage.
- Loss of Rab25 was associated with poorer survival in colon cancer patients.
- Rab25 deficiency in mouse models led to increased tumorigenesis.
Takeaway
Rab25 helps keep colon cells healthy, and when it's missing, it can lead to cancer.
Methodology
The study involved genetic deletion of Rab25 in mouse models and analysis of its effects on tumor development.
Limitations
The study primarily used mouse models, which may not fully replicate human cancer biology.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website